Cambridge, Massachusetts-based biotechnology startup Laronde has raised $440 million in Series B financing. The investors included Flagship Pioneering, T. Rowe Price Associates, Inc., Invus, Canada Pension Plan Investment Board, Fidelity Management & Research Company, BlackRock and Federated Hermes Kaufmann Funds.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: